Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Comparative outcomes of lisocabtagene maraleucel versus an external control arm in third-line or later relapsed or refractory follicular lymphoma.
Journal: Leukemia & lymphoma
Published: April 29, 2026
Indirect Treatment Comparisons of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in Third-Line or Later Relapsed or Refractory Follicular Lymphoma.
Journal: Advances in therapy
Published: December 19, 2025
Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma.
Journal: Experimental hematology & oncology
Published: July 24, 2024
Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Journal: Nature medicine
Published: July 09, 2024
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Journal: Nature medicine
Published: January 12, 2024
Statistical Assessment of Depth Normalization for Small RNA Sequencing.
Journal: JCO clinical cancer informatics
Published: June 30, 2020
Deciphering human ribonucleoprotein regulatory networks.
Journal: Nucleic acids research
Published: May 04, 2018
Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.
Journal: Future oncology (London, England)
Published: March 30, 2018
The transcription factor ERG recruits CCR4-NOT to control mRNA decay and mitotic progression.
Journal: Nature structural & molecular biology
Published: January 14, 2016
Structural basis underlying CAC RNA recognition by the RRM domain of dimeric RNA-binding protein RBPMS.
Journal: Quarterly reviews of biophysics
Published: September 09, 2015
Identification of the RNA recognition element of the RBPMS family of RNA-binding proteins and their transcriptome-wide mRNA targets.
Journal: RNA (New York, N.Y.)
Published: May 27, 2014
Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
Journal: Genes, chromosomes & cancer
Published: April 01, 2014
Last Updated: 09/26/2026